On the binding reaction of loratadine with human serum acute phase protein alpha 1-acid glycoprotein

References

• Ajmal, M. R. (2016). Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 159, 199–208. https://doi.org/10.1016/j.saa.2016.01.049
   PubMed Web of Science ®Google Scholar
• Ajmal, M. R. (2017). Insight into the Interaction of antitubercular and anticancer compound Clofazimine with Human Serum Albumin: Spectroscopy and molecular modelling. Journal of Biomolecular Structure and Dynamics, 35(1), 46–57. https://doi.org/10.1080/07391102.2015.1132258
   PubMed Web of Science ®Google Scholar
• Ajmal, M. R. (2019). Biophysical insights into the interaction of clofazimine with human alpha 1-acid glycoprotein: A multitechnique approach. Journal of Biomolecular Structure and Dynamics, 37(6), 1390–1401. https://doi.org/10.1080/07391102.2018.1461686
   PubMed Web of Science ®Google Scholar
• Almutairi, F. M., Ajmal, M. R., Siddiqi, M. K., Amir, M., & Khan, R. H. (2020). Multi-spectroscopic and molecular docking technique study of the azelastine interaction with human serum albumin. Journal of Molecular Structure, 1201, 127147. https://doi.org/10.1016/j.molstruc.2019.127147
   Web of Science ®Google Scholar
• Amroabadi, M. K., Taheri-Kafrani, A., Heidarpoor Saremi, L., & Rastegari, A. A. (2018). Spectroscopic studies of the interaction between alprazolam and apo-human serum transferrin as a drug carrier protein. International Journal of Biological Macromolecules, 108, 263–271.
   PubMed Web of Science ®Google Scholar
• Baradaran Rahimi, V., Ghadiri, M., Ramezani, M., & Askari, V. R. (2020). Anti-inflammatory and anti-cancer activities of pomegranate and its constituent, ellagic acid: Evidence from cellular, animal, and clinical studies. Phytotherapy Research, 34(4), 685–720. https://doi.org/10.1002/ptr.6565
   PubMed Web of Science ®Google Scholar
• Barenholtz, H. A., & McLeod, D. C. (1989). Loratadine: A nonsedating antihistamine with once-daily dosing. DICP, 23(6), 445–450. https://doi.org/10.1177/106002808902300601
   PubMedGoogle Scholar
• Brasca, R., Romero, M. A., Goicoechea, H. C., Kelterer, A.-M., & Fabian, W. M. F. (2013). Spectroscopic behavior of loratadine and desloratadine in different aqueous media conditions studied by means of TD-DFT calculations. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 115, 250–258., https://doi.org/10.1016/j.saa.2013.06.037
   PubMed Web of Science ®Google Scholar
• Chandel, T. I., Masroor, A., Siddiqi, M. K., Siddique, I. A., Jahan, I., Ali, M., Nayeem, S. M., Uversky, V. N., & Khan, R. H. (2019). Molecular basis of the inhibition and disaggregation of thermally-induced amyloid fibrils of human serum albumin by an anti-Parkinson's drug, benserazide hydrochloride. Journal of Molecular Liquids, 278, 553–567. https://doi.org/10.1016/j.molliq.2018.12.127
   Web of Science ®Google Scholar
• Clissold, S. P., Sorkin, E. M., & Goa, K. L. (1989). Loratadine. Drugs, 37(1), 42–57. https://doi.org/10.2165/00003495-198937010-00003
   PubMed Web of Science ®Google Scholar
• Cuboni, S., Devigny, C., Hoogeland, B., Strasser, A., Pomplun, S., Hauger, B., Höfner, G., Wanner, K. T., Eder, M., Buschauer, A., Holsboer, F., & Hausch, F. (2014). Loratadine and analogues: Discovery and preliminary structure–activity relationship of inhibitors of the amino acid transporter B0AT2. Journal of Medicinal Chemistry, 57(22), 9473–9479. https://doi.org/10.1021/jm501086v
   PubMed Web of Science ®Google Scholar
• Denson, D., Coyle, D., Thompson, G., & Myers, J. (1984). Alpha1-acid glycoprotein and albumin in human serum bupivacaine binding. Clinical Pharmacology & Therapeutics, 35(3), 409–415. https://doi.org/10.1038/clpt.1984.51
   PubMed Web of Science ®Google Scholar
• Dente, L. (1987). Structure and expression of the genes coding for human alpha 1-acid glycoprotein. The EMBO Journal, 6(8), 2289–2296. https://doi.org/10.1002/j.1460-2075.1987.tb02503.x
   PubMed Web of Science ®Google Scholar
• Elfaki, I., Knitsch, A., Matena, A., & Bayer, P. (2013). Identification and characterization of peptides that bind the PPIase domain of Parvulin17. Journal of Peptide Science, 19(6), 362–369. https://doi.org/10.1002/psc.2510
   PubMed Web of Science ®Google Scholar
• Fournier, T., Medjoubi-N, N., & Porquet, D. (2000). Alpha-1-acid glycoprotein. Biochimica et Biophysica Acta (BBA) – Protein Structure and Molecular Enzymology, 1482(1–2), 157–171. https://doi.org/10.1016/S0167-4838(00)00153-9
   PubMed Web of Science ®Google Scholar
• Furkan, M., & Khan, R. H. (2020). Process, outcomes and possible elimination of aggregation with special reference to heme proteins; Likely remediation of proteinopathies. Current Protein & Peptide Science, 21(6), 573–583. https://doi.org/10.2174/1389203721666200204122732
   PubMed Web of Science ®Google Scholar
• Haria, M., Fitton, A., & Peters, D. H. (1994). Loratadine. Drugs, 48(4), 617–637. https://doi.org/10.2165/00003495-199448040-00009
   PubMed Web of Science ®Google Scholar
• Hochepied, T. (2003). A 1-Acid glycoprotein: An acute phase protein with inflammatory and immunomodulating properties. Cytokine & Growth Factor Reviews, 14(1), 25–34. https://doi.org/10.1016/S1359-6101(02)00054-0
   PubMed Web of Science ®Google Scholar
• Huang, Z., & Ung, T. (2013). Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Current Drug Metabolism, 14(2), 226–238. PMID: 23092311.
   PubMed Web of Science ®Google Scholar
• Ingram, N., Dishinger, C., Wood, J., Hutzler, J. M., Smith, S., & Huskin, M. (2019). Effect of the plasticizer DEHP in blood collection bags on human plasma fraction unbound determination for alpha-1-acid glycoprotein (AAG) binding drugs. The AAPS Journal, 21(1), 5. https://doi.org/10.1208/s12248-018-0276-8
   Web of Science ®Google Scholar
• Kamei, C. (2000). Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats. Brain Research, 887(1), 183–186. https://doi.org/10.1016/S0006-8993(00)03041-9
   PubMed Web of Science ®Google Scholar
• Kay, G. G. (1997). Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. Archives of Internal Medicine, 157(20), 2350–2356. https://doi.org/10.1001/archinte.1997.00440410082009
   PubMed Web of Science ®Google Scholar
• Khorsand Ahmadi, S., Mahmoodian Moghadam, M., Mokaberi, P., Reza Saberi, M., & Chamani, J. (2015). A comparison study of the interaction between β-lactoglobulin and retinol at two different conditions: Spectroscopic and molecular modeling approaches. Journal of Biomolecular Structure and Dynamics, 33(9), 1880–1898. https://doi.org/10.1080/07391102.2014.977351.
   PubMed Web of Science ®Google Scholar
• Kiss, R., Koveri, Z., & Kesera, G. M. (2004). Homology modelling and binding site mapping of the human histamine H1 receptor. European Journal of Medicinal Chemistry, 39(11), 959–967. https://doi.org/10.1016/j.ejmech.2004.07.009
   PubMed Web of Science ®Google Scholar
• Kopecka, V., Jr. (2003). Structure of human α1-acid glycoprotein and its high-affinity binding site. Biochemical and Biophysical Research Communications, 300(1), 41–46.
   PubMed Web of Science ®Google Scholar
• Kreutner, W. (1987). Antiallergic activity of loratadine, a non-sedating antihistamine. Allergy, 42(1), 57–63. https://doi.org/10.1111/j.1398-9995.1987.tb02188.x
   PubMed Web of Science ®Google Scholar
• Lippert, U. (1995). Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Experimental Dermatology, 4(4), 272–276. https://doi.org/10.1111/j.1600-0625.1995.tb00257.x
   PubMedGoogle Scholar
• Miyano, K., Eto, M., Hitomi, S., Matsumoto, T., Hasegawa, S., Hirano, A., Nagabuchi, K., Asai, N., Uzu, M., Nonaka, M., Omiya, Y., Kaneko, A., Ono, K., Fujii, H., Higami, Y., Kono, T., & Uezono, Y. (2020). The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis. Scientific Reports, 10(1), 1–13. https://doi.org/10.1038/s41598-019-57192-2
   PubMed Web of Science ®Google Scholar
• Nakamura, K. (1998). Serum levels of interleukin-6, alpha1-acid glycoprotein, and corticosterone in two-week-old chickens inoculated with Escherichia coli lipopolysaccharide. Poultry Science, 77(6), 908–911. https://doi.org/10.1093/ps/77.6.908
   PubMed Web of Science ®Google Scholar
• Noehr-Jensen, L. (2006). The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers. European Journal of Clinical Pharmacology, 62(6), 437–445. https://doi.org/10.1007/s00228-006-0139-6
   PubMed Web of Science ®Google Scholar
• Pavalache, G., Matei, N., Popescu, A., & Schroder, V. (2015). Applications of a DAD-HPLC method for determination of loratadine on biological samples. Ovidius University Annals of Chemistry, 26(1), 32–36. https://doi.org/10.1515/auoc-2015-0006
   Web of Science ®Google Scholar
• Pitekova, B., Uhlikova, E., Kupcova, V., Durfinova, M., Mojto, V., & Turecky, L. (2019). Can alpha-1-acid glycoprotein affect the outcome of treatment in a cancer patient? Bratislavske Lekarske Listy, 120(1), 9–14., https://doi.org/10.4149/BLL_2018_134
   PubMed Web of Science ®Google Scholar
• Salahuddin, P., Khan, R. H., & Uversky, V. N. (2020). Comprehensive analysis of the molecular docking of small molecule inhibitors to the AÎ21–40 peptide and its Osaka-mutant: Insights into the molecular mechanisms of AÎ2-peptide inhibition. Journal of Biomolecular Structure and Dynamics, 38(15), 4536–4541. https://doi.org/10.1080/07391102.2019.1697367
   PubMed Web of Science ®Google Scholar
• Sengupta, P., Sardar, P. S., Roy, P., Dasgupta, S., & Bose, A. (2018). Investigation on the interaction of Rutin with serum albumins: Insights from spectroscopic and molecular docking techniques. Journal of Photochemistry and Photobiology B: Biology, 183, 101–110. https://doi.org/10.1016/j.jphotobiol.2018.04.019
   PubMed Web of Science ®Google Scholar
• Sherafudeen, S. P., & Vasantha, P. V. (2015). Development and evaluation of in situ nasal gel formulations of loratadine. Research in Pharmaceutical Sciences, 10(6), 466.
   PubMed Web of Science ®Google Scholar
• Siddiqi, M. K., Alam, P., Chaturvedi, S. K., Nusrat, S., Ajmal, M. R., Abdelhameed, A. S., & Khan, R. H. (2017). Probing the interaction of cephalosporin antibiotic ceftazidime with human serum albumin: A biophysical investigation. International Journal of Biological Macromolecules, 105, 292–299. https://doi.org/10.1016/j.ijbiomac.2017.07.036
   PubMed Web of Science ®Google Scholar
• Smith, S. A., & Waters, N. J. (2019). Pharmacokinetic and Pharmacodynamic Considerations for Drugs Binding to Alpha-1-Acid Glycoprotein. Pharmaceutical Research, 36(2), 30. https://doi.org/10.1007/s11095-018-2551-x
   Web of Science ®Google Scholar
• ter Laak, A. M., Bijloo, G. J., Fischer, M. J. E., Donnéop den Kelder, G. M., Wilting, J., & Timmerman, H. (1996). Serum protein binding of histamine H1-antagonists. A comparative study on the serum protein binding of a sedating ([3H] mepyramine) and a non-sedating H1-antagonist ([3H] loratadine). European Journal of Pharmaceutical Sciences, 4(5), 307–319. https://doi.org/10.1016/0928-0987(96)00172-8
   Web of Science ®Google Scholar
• Urien, S., Barré, J., Morin, C., Paccaly, A., Montay, G., & Tillement, J. P. (1996). Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein. Investigational New Drugs, 14(2), 147–151. https://doi.org/10.1007/BF00210785
   PubMed Web of Science ®Google Scholar
• Wani, T. A., Bakheit, A. H., Abounassif, M. A., & Zargar, S. (2018). Study of interactions of an anticancer drug neratinib with bovine serum albumin: Spectroscopic and molecular docking approach. Frontiers in Chemistry, 6, 47. https://doi.org/10.3389/fchem.2018.00047
   PubMed Web of Science ®Google Scholar
• Zaidi, N., Ahmad, E., Rehan, M., Rabbani, G., Ajmal, M. R., Zaidi, Y., Subbarao, N., & Khan, R. H. (2013). Biophysical insight into furosemide binding to human serum albumin: A study to unveil its impaired albumin binding in uremia. The Journal of Physical Chemistry B, 117(9), 2595–2604. https://doi.org/10.1021/jp3069877
   PubMed Web of Science ®Google Scholar
• Zaidi, N., Ajmal, M. R., Rabbani, G., Ahmad, E., & Khan, R. H. (2013). A comprehensive insight into binding of hippuric acid to human serum albumin: A study to uncover its impaired elimination through hemodialysis. PLoS One, 8(8), e71422. https://doi.org/10.1371/journal.pone.0071422
   PubMed Web of Science ®Google Scholar
• Zakariya, S. M., Furkan, M., Zaman, M., Chandel, T. I., Ali, S. M., Uversky, V. N., & Khan, R. H. (2020). An in-vitro elucidation of inhibitory potential of carminic acid: Possible therapeutic approach for neurodegenerative diseases. Journal of Molecular Liquids, 303, 112692. https://doi.org/10.1016/j.molliq.2020.112692
   Web of Science ®Google Scholar
• Zhang, D. (2017). Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis. Biomarkers in Medicine, 11(5), 423–430. https://doi.org/10.2217/bmm-2016-0284
   PubMed Web of Science ®Google Scholar
• Zhou, B., Qi, Z.-D., Xiao, Q., Dong, J.-X., Zhang, Y.-Z., & Liu, Y. (2007). Interaction of loratadine with serum albumins studied by fluorescence quenching method. Journal of Biochemical and Biophysical Methods, 70(5), 743–747. https://doi.org/10.1016/j.jbbm.2007.04.001
   PubMedGoogle Scholar
• Zsila, F., & Iwao, Y. (2007). The drug binding site of human a1-acid glycoprotein: Insight from induced circular dichroism and electronic absorption spectra. Biochimica et Biophysica Acta (BBA) – General Subjects, 1770(5), 797–809. https://doi.org/10.1016/j.bbagen.2007.01.009
   PubMed Web of Science ®Google Scholar
• Zsila, F., & Mády, G. (2008). Biliverdin is the endogenous ligand of human serum α1-acid glycoprotein. Biochemical and Biophysical Research Communications, 372(3), 503–507. https://doi.org/10.1016/j.bbrc.2008.05.090
   PubMed Web of Science ®Google Scholar